Peginterferon and Entecavir Combination Therapy Improves Outcome of Non–Early Response Hepatitis B e Antigen–Positive Patients

BACKGROUND: The efficacy of nucleot(s)ide analogs (NAs) and pegylated interferon (PegIFN) combination therapy for hepatitis B e antigen–positive (HBeAg(+)) patients is still controversial. Whether PegIFN and entecavir (ETV) combination therapy could provide a greater benefit for HBeAg(+) patients wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lu, Lin, Lanyi, Zhou, Huijuan, Tang, Weiliang, Wang, Hui, Cai, Wei, Bao, Shisan, Guo, Simin, Xie, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050793/
https://www.ncbi.nlm.nih.gov/pubmed/33889654
http://dx.doi.org/10.1093/ofid/ofaa462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050793/
https://www.ncbi.nlm.nih.gov/pubmed/33889654
http://dx.doi.org/10.1093/ofid/ofaa462

Ejemplares similares